FDA approval of new drugs

Jill Jin

doi:10.1001/jama.2013.285612

FDA approval of new drugs

Jill Jin^*

^*Corresponding author for this work

Medicine, General Medicine Division

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	978
Number of pages	1
Journal	JAMA - Journal of the American Medical Association
Volume	311
Issue number	9
DOIs	https://doi.org/10.1001/jama.2013.285612
State	Published - Mar 5 2014

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2013.285612

Cite this

@article{1ab610e3518f449c84dce469f118659a,

title = "FDA approval of new drugs",

author = "Jill Jin",

year = "2014",

month = mar,

day = "5",

doi = "10.1001/jama.2013.285612",

language = "English (US)",

volume = "311",

pages = "978",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - FDA approval of new drugs

AU - Jin, Jill

PY - 2014/3/5

Y1 - 2014/3/5

UR - http://www.scopus.com/inward/record.url?scp=84897018314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897018314&partnerID=8YFLogxK

U2 - 10.1001/jama.2013.285612

DO - 10.1001/jama.2013.285612

M3 - Comment/debate

C2 - 24595795

AN - SCOPUS:84897018314

SN - 0098-7484

VL - 311

SP - 978

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 9

ER -

FDA approval of new drugs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this